Shares of Cytokinetics, ... Stock Market News, Jan. 8, 2024: S&P 500 Rebounds, Boosted by the Magnificent Seven Boeing shares fell, weighing on the Dow industrials; Nvidia climbs.Stock prices may also move more quickly in this environment. Investors who anticipate trading during these times are strongly advised to use limit orders. Data is delayed at least 15 minutes.The opening auction price ticked up from the premarket to $78.46, on a much higher volume than typical for the last 30 days. The stock showed some weakness ...Cytokinetics Stock Earnings. The value each CYTK share was expected to gain vs. the value that each CYTK share actually gained. Cytokinetics ( CYTK) reported Q3 2023 earnings per share (EPS) of -$1.35, missing estimates of -$0.74 by 81.36%. In the same quarter last year, Cytokinetics 's earnings per share (EPS) was -$1.52.With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stoc...Apellis Pharmaceuticals Inc. 68.78. +1.20. +1.78%. Get Cytokinetics Inc (CYTK:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.The potential price and other terms couldn’t be learned. Cytokinetics is focused on so-called muscle activators and inhibitors as ... The Motley Fool: Epic Bundle - 3x Expert Stock ...Check the Cytokinetics stock price today on the NASDAQ stock exchange and access historical CYTK stock price chart. Get the latest Cytokinetics stock ...Historical daily share price chart and data for Cytokinetics since 2004 adjusted for splits and dividends. The latest closing stock price for Cytokinetics as of February 16, 2024 is 76.89.. The all-time high Cytokinetics stock closing price was 108.06 on January 08, 2024.; The Cytokinetics 52-week high stock price is 110.25, which is 43.4% above the …3 days ago · Rates Futures Crypto Home Investing Quotes Stocks United States CYTK Overview Stock Screener Earnings Calendar Sectors Nasdaq | CYTK U.S.: Nasdaq Cytokinetics Inc. Watch list NEW Set a price... 10.02%. Get the latest Cytokinetics, Inc. (CYTK) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …Cytokinetics, Incorporated Common Stock (CYTK) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Amgen Inc. -0.99%. $164.04B. CYTK | Complete Cytokinetics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Cytokinetics Has Record Gain as Heart Drug Succeeds in Trial. Cytokinetics Inc. said its experimental drug helped patients with a genetic heart ailment in a closely watched trial. The drug ...Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference; The biotech stocks to own in 2024, according to Piper Sandler; Cytokinetics price target raised to $78 from $48 at ...Cytokinetics Inc share price live 76.89, this page displays NASDAQ CYTK stock exchange data. View the CYTK premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cytokinetics Inc real time stock price chart below. You can find more ...What this means: Cytokinetics (CYTK) gets an Overall Rank of 69, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. Get the latest Cytokinetics, Inc. (KK3A) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Get the latest Cytokinetics, Incorporated (CYTK) stock news and headlines to help you in your trading and investment decisions.Historical daily share price chart and data for Cytokinetics since 2004 adjusted for splits and dividends. The latest closing stock price for Cytokinetics as of February 16, 2024 is 76.89.. The all-time high Cytokinetics stock closing price was 108.06 on January 08, 2024.; The Cytokinetics 52-week high stock price is 110.25, which is 43.4% above the …Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may...The current price Cytokinetics (CYTK) is trading at is $75.80, which is within the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. People Also WatchFeb 13, 2024 · Analyst Salim Syed of Mizuho Securities maintained a Buy rating on Cytokinetics (CYTK – Research Report), with a price target of $103.00. Salim Syed has given his Buy rating due to a combination ... Feb 13, 2024 · The Cytokinetics stock price gained 3.21% on the last trading day (Friday, 23rd Feb 2024), rising from $75.59 to $78.02. During the last trading day the stock fluctuated 4.79% from a day low at $75.86 to a day high of $79.49. The price has fallen in 6 of the last 10 days and is down by -1.17% for this period. On top of that, the share price is up 129% in about a quarter. ... Of course Cytokinetics may not be the best stock to buy. So you may wish to see this free collection of growth stocks.Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, includi...According to the current price, Cytokinetics is 292.92% away from the 52-week low. What was the 52-week high for Cytokinetics stock? The high in the last 52 weeks of Cytokinetics stock was 110.00. Cytokinetics (CYTK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. ... UBS also downgraded the stock to a Hold with a $92.00 price target ...For more than 25 years, Cytokinetics, a late-stage biopharmaceutical company, has been finding strength in science as a pioneer in the field of muscle biology working to discover, develop, and commercialize potential medicines that may preserve and extend independence in people suffering from debilitating diseases. See our story.Cytokinetics (CYTK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. ... UBS also downgraded the stock to a Hold with a $92.00 price target ...Get the latest Cytokinetics, Inc. (KK3A) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Jan 12, 2024 · Shares of Cytokinetics plummeted further Thursday after the Journal reported that Novartis has backed away from a deal to acquire the heart-drug developer. Cytokinetics stock was recently down 24%. MT. UBS Downgrades Cytokinetics to Neutral From Buy, Adjusts Price Target to $92 From $61. Jan. 24. MT. Mizuho Securities Boosts Price Target on Cytokinetics to $103 From $80, Keeps Buy Rating. Jan. 19. MT. Cytokinetics Insider Sold Shares Worth $425,700, According to a Recent SEC Filing. Jan. 12. View Cytokinetics (CYTK) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with the ...CYTK stock tacked on another 15%-plus on Jan. 8 when a rumor suggested Novartis could be entertaining a buyout bid for Cytokinetics. That put CYTK stock's gain at more than 141% over two weeks. Cytokinetics (CYTK) Stock Price Performance. Cytokinetics (CYTK) Stock Key Data. ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months. 2 days ago · What is the target price for Cytokinetics (CYTK) stock? A. The latest price target for Cytokinetics ( NASDAQ: CYTK) was reported by UBS on Wednesday, January 24, 2024. The analyst firm set a price ... Jan 9, 2024 · Shares of Cytokinetics with a market capitalization of over $9 billion, as of Friday's closing price, have more than tripled in value since Oct. 31, when reports of the company attracting takeover ... Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide...CYTK Stock 12 Months Forecast. $92.00. (11.52% Upside) Based on 17 Wall Street analysts offering 12 month price targets for Cytokinetics in the last 3 months. The average price target is $92.00 with a high forecast of $122.00 and a low forecast of $54.00. The average price target represents a 11.52% change from the last price of $82.50.What is Cytokinetics Inc(CYTK)'s stock price today? The current price of CYTK is $76.89. The 52 week high of CYTK is $110.25 and 52 week low is $25.98. When is next earnings date of Cytokinetics Inc(CYTK)? The next earnings date of Cytokinetics Inc(CYTK) is 2024-02-27. Does Cytokinetics Inc(CYTK) pay dividends? ...Cytokinetics’ share price fell 16% yesterday on news that Novartis has dropped its pursuit of the biotech. ... One problem for potential buyers is the phase 3 data sent the stock into overdrive.With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stoc...Find the latest Cytek Biosciences, Inc. (CTKB) stock quote, history, news and other vital information to help you with your stock trading and investing.Cytokinetics GAAP EPS of -$1.52 misses by $0.35, revenue of $2.5M misses by $0.73M. Get the latest news and real-time alerts from Cytokinetics, Incorporated (CYTK) stock at Seeking Alpha.3 days ago · Stock Price Forecast. The 17 analysts with 12-month price forecasts for Cytokinetics stock have an average target of 73.76, with a low estimate of 49 and a high estimate of 108. The average target predicts a decrease of -5.94% from the current stock price of 78.42. On February 9, 2024, Cytokinetics, Incorporated (NASDAQ:CYTK) stock closed at $76.94 per share. One-month return of Cytokinetics, Incorporated (NASDAQ:CYTK) was -10.12%, and its shares gained 76. ...Find the historical stock prices of Cytokinetics (CYTK)Jan 9, 2024 · Shares of Cytokinetics, Incorporated (CYTK Quick Quote CYTK - Free Report) ... This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating ... Oct 27, 2022 · Related news How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month. 2/09/2024 Cytokinetics has shucked off two high-profile setbacks, leading CYTK stock to double as it ... Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks. View the real-time CYTK price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper ...Apellis Pharmaceuticals Inc. 68.78. +1.20. +1.78%. Get Cytokinetics Inc (CYTK:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, includi...CYTK) stock’s latest price update. Cytokinetics Inc (NASDAQ: CYTK) has seen a decline in its stock price by -1.19 in relation to its previous close of 76.50. However, the company has experienced a -1.19% decline in its stock price over the last five trading sessions. GlobeNewsWireThe biotech company showed 0% earnings growth in its most recent report. Sales rose -85%. Cytokinetics stock earns the No. 149 rank among its peers in the Medical-Biomed/Biotech industry group.Get the latest Cytokinetics, Inc. (KK3A) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Cytokinetics will settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at Cytokinetics’ election. The initial conversion rate is 19.5783 shares of common stock per $1,000 principal amount of notes, which represents an initial conversion price …Apellis Pharmaceuticals Inc. 68.78. +1.20. +1.78%. Get Cytokinetics Inc (CYTK:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Stock price history for Cytokinetics (CYTK) Highest end of day price: $108.06 USD on 2024-01-08. Lowest end of day price: $3.07 USD on 2014-10-10. Stock price history of Cytokinetics from 2004 to 2024. Stock price for similar companies or competitors. Company Stock price Change 1d% Country; Amgen. AMGN. $294.43: …In another report released on October 30, J.P. Morgan also maintained a Buy rating on the stock with a $48.00 price target. ... Cytokinetics price target lowered to $48 from $54 at JPMorgan;-- Cytokinetics has an average rating of outperform and price targets ranging from $42.40 to $122, according to analysts polled by Capital IQ. Price: 81.22, Change: -1.52, Percent Change: -1.84 ...Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real-time price. Currency in USD. Add to watchlist. 81.87 +0.62 (+0.76%) At close: 04:00PM EST. 79.95 -1.92 ( …Cytokinetics has a market cap or net worth of $7.56 billion as of February 7, 2024. Its market cap has increased by 94.62% in one year. Market Cap ... Formula: Market Cap = Stock Price * Shares Outstanding. Full Definition. Related Stocks. Company Market Cap; ImmunoGen: 8.19B: Ascendis Pharma: 8.09B: Apellis Pharmaceuticals: 8.08B ...Cytokinetics Has Record Gain as Heart Drug Succeeds in Trial. Cytokinetics Inc. said its experimental drug helped patients with a genetic heart ailment in a closely watched trial. The drug ...Cytokinetics (CYTK) delivered earnings and revenue surprises of -87.50% and 98.47%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?CYTK Cytokinetics · High. 78.000 · Low. 76.010 · Volume. 1.14M · Open. 76.620 · Pre Close. 76.890 · Turnover. 87.30M · Turnover Rat...Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends ...CYTK Cytokinetics · High. 78.000 · Low. 76.010 · Volume. 1.14M · Open. 76.620 · Pre Close. 76.890 · Turnover. 87.30M · Turnover Rat...Cytokinetics, Incorporated Common Stock (CYTK) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. CYTK support price is $34.79 and resistance is $37.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CYTK stock will trade within this expected range on the day. View …Jan 8, 2024 · How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month. 2/09/2024 Cytokinetics has shucked off two high-profile setbacks, leading CYTK stock to double as it looks to take ... Jan 9, 2024 · Shares of Cytokinetics, Incorporated (CYTK Quick Quote CYTK - Free Report) ... This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating ... The last closing price for Cytokinetics was $78.56. Over the last year, Cytokinetics shares have traded in a share price range of $ 25.98 to $ 110.25. Cytokinetics currently has 98,053,647 shares ...Interactive stock price chart for Cytokinetics, Incorporated (CYTK) with real-time updates, full price history, technical analysis and more.Related news How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month. 2/09/2024 Cytokinetics has shucked off two high-profile setbacks, leading CYTK stock to double as it ...Get the latest Cytokinetics, Inc. (KK3A) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Cytokinetics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CYTK stock price.5 days ago · Date Requested Open Price Day High Day Low Closing Price Volume Split Adjustment Factor; February 20, 2024: $76.62: $78.00: $76.01: $76.89: 1,136,377: 1:1: February ... View Cytokinetics (NASDAQ:CYTK) historical prices, past price performance, and an advanced CYTK stock chart at MarketBeat.Stock split history for Cytokinetics (CYTK) Cytokinetics stock (symbol: CYTK) underwent a total of 1 stock split. The stock split occured on June 25th, 2013. One CYTK share bought prior to June 25th, 2013 would equal to …On average, Wall Street analysts predict. that Cytokinetics's share price could reach $83.36 by Jan 24, 2025. The average Cytokinetics stock price prediction forecasts a potential upside of 8.42% from the current CYTK share price of $76.89.CYTK - Cytokinetics, Incorporated Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGS)4 days ago · Cytokinetics (CYTK) Stock Price, News & Analysis $76.50 -0.39 (-0.51%) (As of 02/21/2024 ET) Compare Today's Range $75.66 $77.35 50-Day Range $35.72 $108.06 52-Week Range $25.98 $110.25 Volume 974,122 shs Average Volume 3.94 million shs Market Capitalization $7.50 billion P/E Ratio N/A Dividend Yield N/A Price Target $73.94 Get the latest Cytokinetics, Incorporated (CYTK) stock news and headlines to help you in your trading and investing decisions. B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Cytokinetics (CYTK – Research Report) yesterday and set a price target of $122.00. Mayank Mamtani’s Buy rating is based on ...Cytokinetics, Inc. (CYTK) Stock Price & News - Google Finance Markets Dow Jones 39,069.11 +1.18% +456.87 S&P 500 5,087.03 +2.11% +105.23 Nasdaq 16,041.62 +2.96% +460.75 2,013.84 +0.96% +19.09... Cytokinetics shares skyrocketed to a 19-year high, advancing more than 80% in late Wednesday trading to about $82.50. Cytokinetics Inc. reported positive results Wednesday from a key Phase 3 study ...The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the ...Related news How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month. 2/09/2024 Cytokinetics has shucked off two high-profile setbacks, leading CYTK stock to double as it ...The last closing price for Cytokinetics was $78.56. Over the last year, Cytokinetics shares have traded in a share price range of $ 25.98 to $ 110.25. Cytokinetics currently has 98,053,647 shares ...
The lead drug for Cytokinetics is omecamtiv which is being developed in partnership with Amgen for the treatment of chronic heart failure, a quite different indication. We are expecting phase 3 results from a huge 8,000 patient trial in 4Q, 2020. Cytokinetics is also developing CK-274 which is a direct competitor and fast follower to mavacamten.. Download pinterest image
Jan 9, 2024 · Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report Cytokinetics, Incorporated (CYTK) : Free Stock Analysis Report AbbVie Inc. (ABBV) : Free Stock Analysis Report Adjusted debt-to-capital ratio. A solvency ratio calculated as adjusted total debt divided by adjusted total debt plus adjusted total equity. Cytokinetics Inc. adjusted debt-to-capital ratio deteriorated from 2020 to 2021 and from 2021 to 2022. An indicator of profitability, calculated as adjusted net income divided by total revenue. Cytokinetics (CYTK) closed the last trading session at $35.10, gaining 29.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...Cytokinetics, Incorporated (KK3A.FRA) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Cytokinetics, Incorporated | Deutsche Boerse ...The opening auction price ticked up from the premarket to $78.46, on a much higher volume than typical for the last 30 days. The stock showed some weakness ...3 days ago · Stock Price Forecast. The 17 analysts with 12-month price forecasts for Cytokinetics stock have an average target of 73.76, with a low estimate of 49 and a high estimate of 108. The average target predicts a decrease of -5.94% from the current stock price of 78.42. Find the historical stock prices of Cytokinetics (CYTK)Get the latest Cytokinetics, Incorporated (CYTK) stock news and headlines to help you in your trading and investing decisions. Cytokinetics (CYTK) Stock Price Performance. Cytokinetics (CYTK) Stock Key Data. ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months. Reldesemtiv. CK-3773274. Revenue. US$ 70.4 million (2021) [1] Number of employees. 253 (December 2021) [1] Website. www .cytokinetics .com. Cytokinetics, Inc., is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases ... Cytokinetics stock is now considered extended and out of buy range after clearing a 47.90 buy point in a first-stage consolidation. ... Fed Minutes: Stock Prices Becoming An Inflation Threat; ...Here's Why Cytokinetics Stock Tanked on Thursday. ... Current Price. $78.73. Price as of January 30, 2024, 4:00 p.m. ET ... What happened. Shares of Cytokinetics (CYTK-1.57%), a clinical-stage ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an....